Form: S-8

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 3, 2017


Exhibit 24.1
 
REXAHN PHARMACEUTICALS, INC.
 
Power of Attorney
 
Each of the undersigned officers and directors of Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby constitutes and appoints Peter D. Suzdak and Tae Heum Jeong, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution, for him and in his name, place and stead, in any and all capacities, to sign the registration statement on Form S-8 (the “Registration Statement”) of the Company relating to securities of the Company acquired under or to be offered under the Rexahn Pharmaceuticals 2013 Stock Option Plan, and any and all amendments (including post-effective amendments) to the Registration Statement, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their substitutes, may lawfully do or cause to be done by virtue hereof.

Name and Title
     
Date
         
/s/ Peter D. Suzdak
     
May 2, 2017
Peter D. Suzdak
       
Chief Executive Officer and Director
       
         
/s/ Tae Heum Jeong
     
May 2, 2017
Tae Heum Jeong
       
Chief Financial Officer and Secretary        
         
/s/ Peter Brandt
     
May 2, 2017
Peter Brandt
       
Chairman
       
         
/s/ Chang H. Ahn
     
May 1, 2017
Chang H. Ahn
       
Director
       
         
/s/ Charles Beever
     
May 1, 2017
Charles Beever
       
Director
       
         
/s/ Mark Carthy
     
May 2, 2017
Mark Carthy
       
Director
       
         
/s/ Kwang Soo Cheong
     
May 1, 2017
Kwang Soo Cheong
       
Director
       
         
/s/ Richard J. Rodgers
     
May 1, 2017
Richard J. Rodgers
       
Director